Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

NCT00049101 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: erlotinib hydrochloride
DRUG: fluorouracil
DRUG: leucovorin calcium
DRUG: oxaliplatin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]